为药物标识和验证优先考虑遗传发现
Nikita Hukerikar1, Aroon D Hingorani2, Folkert W Asselbergs3
1Institute of Health Informatics, Faculty of Population Health Sciences, University College London, London, UK.
Atherosclerosis
|February 7, 2024
概括
遗传数据有助于药物标的识别,但优先级是关键. 本综述详细介绍了门德尔随机化和生物医学数据库等方法,以优先考虑目标,以非酒精性脂肪肝病蛋白为例.
科学领域:
- 基因组学就是基因组学.
- 药理学 药理学是指药理学的学科.
- 生物信息学是一种生物信息学.
背景情况:
- 高通量基因测序的降低成本使得基因数据可以用于药物标识.
- 许多潜在的药物标需要系统的优先级来进行实验验证.
- 基因证据对于识别和验证新型药物标至关重要.
研究的目的:
- 审查基因指导药物开发的原则,包括功能丧失分析,局部化和门德尔随机化 (MR).
- 介绍生物医学资源,以注释和优先考虑与疾病相关的蛋白质.
- 用非酒精性脂肪性肝病 (NAFLD) 的案例研究来说明目标优先级.
主要方法:
- 讨论遗传分析技术:功能丧失,局部化和门德尔随机化 (MR).
- 使用生物医学数据库进行目标注释:本体学,药物适用性评估,基因/蛋白质表达和途径分析.
- 应用这些方法来识别和优先考虑NAFLD相关的血蛋白.
主要成果:
- 确定了五种蛋白质,对NAFLD参与具有强烈的遗传支持:CYB5A,NT5C,NCAN,TGFBI和DAPK2.
- 所有已识别的蛋白质都在肝脏和脂肪组织中表达.
- TGFBI和DAPK2被确定为潜在的药物目标.
结论:
- 遗传证据与生物医学数据库分析相结合,为药物标识别和优先考虑提供了强大的框架.
- 系统的优先级明确为下游实验验证提供了重要的信息,加速了药物发现.
- 该方法为开发新疗法提供了可操作的见解,如NAFLD所示.
相关概念视频
01:26Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
01:28Structure-Activity Relationships and Drug Design
721
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
721
01:26Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K